GC
ACH

Guggenheim Capital’s Accendra Health ACH Stock Holding History

Guggenheim Capital’s Portfolio ACH Stock Details ACH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-10,901
Closed -$99.2K – 1636
2025
Q2 		$99.2K Sell
10,901
-621
-5% -$4.58K ﹤0.01% 1563
2025
Q1 		$104K Sell
11,522
-1,217
-10% -$12.8K ﹤0.01% 1602
2024
Q4 		$166K Buy
+12,739
New +$170K ﹤0.01% 1616
2024
Q2 		– Sell
-8,225
Closed -$228K – 1920
2024
Q1 		$228K Sell
8,225
-2,151
-21% -$47.8K ﹤0.01% 1748
2023
Q4 		$200K Buy
+10,376
New +$188K ﹤0.01% 1805
2023
Q3 		– Sell
-10,306
Closed -$196K – 1892
2023
Q2 		$196K Sell
10,306
-1,837
-15% -$32.8K ﹤0.01% 1783
2023
Q1 		$177K Buy
+12,143
New +$218K ﹤0.01% 1823
2022
Q3 		– Sell
-6,755
Closed -$213K – 2006
2022
Q2 		$213K Buy
6,755
+733
+12% +$26.6K ﹤0.01% 1924
2022
Q1 		$265K Buy
6,022
+1,361
+29% +$58.4K ﹤0.01% 1934
2021
Q4 		$203K Buy
+4,661
New +$183K ﹤0.01% 2041
2020
Q4 		– Sell
-9,372
Closed -$235K – 2098
2020
Q3 		$235K Buy
+9,372
New +$137K ﹤0.01% 1724
2020
Q1 		– Sell
-55,553
Closed -$287K – 1956
2019
Q4 		$287K Sell
55,553
-52,329
-49% -$336K ﹤0.01% 1848
2019
Q3 		$627K Sell
107,882
-20,897
-16% -$93.7K 0.01% 1526
2019
Q2 		$412K Sell
128,779
-29,406
-19% -$100K ﹤0.01% 1741
2019
Q1 		$649K Sell
158,185
-17,406
-10% -$110K 0.01% 1564
2018
Q4 		$1.11M Buy
175,591
+9,788
+6% +$102K 0.01% 1335
2018
Q3 		$2.74M Buy
165,803
+16,472
+11% +$280K 0.02% 1065
2018
Q2 		$2.5M Sell
149,331
-152,692
-51% -$2.47M 0.02% 1112
2018
Q1 		$4.7M Sell
302,023
-119,721
-28% -$2.13M 0.01% 1051
2017
Q4 		$7.96M Buy
421,744
+118,236
+39% +$2.62M 0.02% 787
2017
Q3 		$8.86M Buy
303,508
+59,733
+25% +$1.76M 0.02% 733
2017
Q2 		$7.85M Sell
243,775
-25,105
-9% -$824K 0.02% 762
2017
Q1 		$9.3M Buy
268,880
+60,122
+29% +$2.15M 0.03% 702
2016
Q4 		$7.37M Buy
208,758
+127,300
+156% +$4.3M 0.02% 797
2016
Q3 		$2.83M Sell
81,458
-43,874
-35% -$1.54M 0.01% 1368
2016
Q2 		$4.68M Sell
125,332
-12,905
-9% -$485K 0.01% 1040
2016
Q1 		$5.59M Buy
138,237
+47,102
+52% +$1.75M 0.02% 933
2015
Q4 		$3.28M Sell
91,135
-7,238
-7% -$262K 0.01% 1268
2015
Q3 		$3.14M Sell
98,373
-5,628
-5% -$192K 0.01% 1293
2015
Q2 		$3.54M Buy
104,001
+24,465
+31% +$824K 0.01% 1348
2015
Q1 		$2.69M Sell
79,536
-10,613
-12% -$370K 0.01% 1537
2014
Q4 		$3.17M Sell
90,149
-8,777
-9% -$296K 0.01% 1392
2014
Q3 		$3.24M Sell
98,926
-135,592
-58% -$4.61M 0.01% 1432
2014
Q2 		$7.97M Buy
234,518
+119,645
+104% +$4.1M 0.02% 963
2014
Q1 		$4.02M Sell
114,873
-12,220
-10% -$431K 0.01% 1257
2013
Q4 		$4.65M Buy
127,093
+6,023
+5% +$221K 0.01% 1129
2013
Q3 		$4.19M Buy
121,070
+3,331
+3% +$117K 0.02% 1182
2013
Q2 		$3.98M Buy
+117,739
New +$3.91M 0.02% 1165

Other funds holding ACH

CCM
Coliseum Capital Management Rowayton, Connecticut $1.22B AUM 18.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $2.18B AUM 0.03% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Guggenheim Capital's ACH Position: Q3 2025 in Review

Guggenheim Capital sold out of Accendra Health (ACH) in Q3 2025, closing a stake of 10,901 shares — an estimated $99.2K sold.

Guggenheim Capital first reported a position in ACH in Q2 2013 and held it in 38 quarters. The position peaked at $9.3M in Q1 2017. 202 funds tracked by Wall St. Rank hold ACH as of Q3 2025.

  • Guggenheim Capital reported no remaining Accendra Health position as of Q3 2025 after selling out during the quarter.
  • Guggenheim Capital sold 10,901 Accendra Health shares in Q3 2025, an estimated $99.2K.
  • Guggenheim Capital first reported a position in Accendra Health in Q2 2013 and held it in 38 quarters.
  • Guggenheim Capital's Accendra Health position peaked at $9.3M in Q1 2017.
  • 202 funds tracked by Wall St. Rank held Accendra Health as of Q3 2025.

Based on Guggenheim Capital's 13F filing for Q3 2025, filed 13 Nov 2025.